Corona Remedies’ IPO, opening on December 8 and closing on December 10, aims to raise ₹655.37 crore through an offer for sale of shares. The price band is set at ₹1,008 to ₹1,062 per share, with strong investor interest reflected in its grey market premium.
Corona Remedies IPO Day 1: Check GMP, subscription status, key dates, review and other details – should you subscribe?
